Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 120 participants.

Also called NCT05122780

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 120 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05122780
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05122780. Randomized; no masking; primary purpose treatment. Start 2021-07-01 (actual); primary completion 2025-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).
Acronym
PROMISE
Condition
Myocardial Infarction With Non-Obstructive Coronary Arteries
Intervention (Procedure)
Coronary angiography
Intervention (Diagnostic test)
OCT imaging
Intervention (Diagnostic test)
Acetylcholine provocative test
Intervention (Diagnostic test)
TT-Echocardiography
Intervention (Diagnostic test)
TE/contrast echocardiography
Intervention (Diagnostic test)
Cardiac magnetic resonance
Intervention (Diagnostic test)
Circulating biomarkers
Intervention (Drug)
Antiplatelet Drug
Intervention (Drug)
Statin
Intervention (Drug)
Beta blocker
Intervention (Drug)
ACEi/ARB
Intervention (Drug)
CCB
Intervention (Drug)
Nitrates
Intervention (Drug)
Anticoagulant
Lead sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS (class: other)
Collaborator
Centro Cardiologico Monzino (class: other)
Collaborator
IRCCS Policlinico S. Donato (class: other)

Record details

Record id
cardio:ct-nct05122780
Content hash
1ec334f0f60dddd33d9ec6caf7de13b3e15678ce6be598e197acaaa2bf8b93a2